Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Large-scale testing (Phase 3)UnknownNCT00146458What this trial is testingUsefulness of FDG-PET for Advanced Cervical CancerWho this might be right forCervical Cancer Chang Gung Memorial Hospital 200
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Not applicableStudy completedNCT01539668What this trial is testingHybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote AreasWho this might be right forCervical Cancer Squamous CellHuman Papilloma Virus InfectionHuman Papilloma Virus-Related Carcinoma+1 more Barretos Cancer Hospital 5,079
Large-scale testing (Phase 3)Study completedNCT00006083What this trial is testingDalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterWho this might be right forCervical CancerChronic Myeloproliferative DisordersLeukemia+6 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05914116What this trial is testingA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors DualityBio Inc. 862
Testing effectiveness (Phase 2)UnknownNCT04886700What this trial is testingStudy of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical CancerWho this might be right forUterine Cervical Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104
Testing effectiveness (Phase 2)Ended earlyNCT03277352What this trial is testingINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Study completedNCT04357873What this trial is testingEfficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsWho this might be right forSquamous Cell Lung CancerVulvar CancerPenile Cancer+3 more UNICANCER 112
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Looking for participantsNCT05969041What this trial is testingStudy of MT-302 in Adults With Advanced or Metastatic Epithelial TumorsWho this might be right forEpithelial Tumors, Malignant Myeloid Therapeutics 48
Testing effectiveness (Phase 2)Ended earlyNCT04230954What this trial is testingCabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical CancerWho this might be right forCervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer+1 more University of South Alabama 5
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01585428What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated CancersWho this might be right forCervical CancerOropharyngeal CancerVaginal Cancer+2 more National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT06535607What this trial is testingStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid TumorsWho this might be right forSub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more AstraZeneca
Early research (Phase 1)UnknownNCT05311618What this trial is testingStudy of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 71
Not applicableLooking for participantsNCT07782164What this trial is testingIrreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)Who this might be right forColorectal CarcinomaRenal CancerBladder Cancer+6 more Amsterdam UMC, location VUmc 27
Testing effectiveness (Phase 2)Looking for participantsNCT06241781What this trial is testingAutologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forAdult Grit Biotechnology 83
Early research (Phase 1)Study completedNCT00513851What this trial is testingPhase 1 Study of OSI-930 in Cancer PatientsWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 60
Testing effectiveness (Phase 2)WithdrawnNCT06099418What this trial is testingEfficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.Who this might be right forHPV-Related Cervical CarcinomaHPV-Related MalignancyCervical Cancer Nykode Therapeutics ASA